232 related articles for article (PubMed ID: 31829179)
1. Prognostic value of HbA1c for in-hospital and short-term mortality in patients with acute coronary syndrome: a systematic review and meta-analysis.
Pan W; Lu H; Lian B; Liao P; Guo L; Zhang M
Cardiovasc Diabetol; 2019 Dec; 18(1):169. PubMed ID: 31829179
[TBL] [Abstract][Full Text] [Related]
2. Impact of diabetes mellitus and hemoglobin A1c level on outcomes among Chinese patients with acute coronary syndrome.
Xiong R; He L; Du X; Dong JZ; Ma CS
Clin Cardiol; 2020 Jul; 43(7):723-731. PubMed ID: 32427378
[TBL] [Abstract][Full Text] [Related]
3. Admission fasting plasma glucose is associated with in-hospital outcomes in patients with acute coronary syndrome and diabetes: findings from the improving Care for Cardiovascular Disease in China - Acute Coronary Syndrome (CCC-ACS) project.
Ye N; Yang L; Wang G; Bian W; Xu F; Ma C; Zhao D; Liu J; Hao Y; Liu J; Yang N; Cheng H;
BMC Cardiovasc Disord; 2020 Aug; 20(1):380. PubMed ID: 32819275
[TBL] [Abstract][Full Text] [Related]
4. Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention.
Liu XJ; Wan ZF; Zhao N; Zhang YP; Mi L; Wang XH; Zhou D; Wu Y; Yuan ZY
Cardiovasc Diabetol; 2015 Aug; 14():110. PubMed ID: 26285575
[TBL] [Abstract][Full Text] [Related]
5. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
Zhang L; Xu C; Liu J; Bai X; Li R; Wang L; Zhou J; Wu Y; Yuan Z
Cardiovasc Diabetol; 2019 Apr; 18(1):52. PubMed ID: 31014348
[TBL] [Abstract][Full Text] [Related]
6. The value of admission HbA(1c) level in diabetic patients with acute coronary syndrome.
Chan CY; Li R; Chan JY; Zhang Q; Chan CP; Dong M; Yan BP; Lam YY; Yu CM
Clin Cardiol; 2011 Aug; 34(8):507-12. PubMed ID: 21717470
[TBL] [Abstract][Full Text] [Related]
7. Serum albumin level for prediction of all-cause mortality in acute coronary syndrome patients: a meta-analysis.
Zhu L; Chen M; Lin X
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31815281
[TBL] [Abstract][Full Text] [Related]
8. Impact of admission glycemia and glycosylated hemoglobin A1c on long-term clinical outcomes of non-diabetic patients with acute coronary syndrome.
Naito R; Miyauchi K; Ogita M; Kasai T; Kawaguchi Y; Tsuboi S; Konishi H; Okazaki S; Kurata T; Daida H
J Cardiol; 2014 Feb; 63(2):106-11. PubMed ID: 24011926
[TBL] [Abstract][Full Text] [Related]
9. Short-term and long-term adverse cardiovascular events across the glycaemic spectrum in patients with acute coronary syndrome: the Gulf Registry of Acute Coronary Events-2.
Alfaleh HF; Alhabib KF; Kashour T; Ullah A; Alsheikhali AA; Al Suwaidi J; Sulaiman K; Al Saif S; Almahmeed W; Asaad N; Amin H; Al-Motarreb A; Mimish L; Hersi A
Coron Artery Dis; 2014 Jun; 25(4):330-8. PubMed ID: 24525788
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.
Liu C; Zhao Q; Ma X; Cheng Y; Sun Y; Zhang D; Liu X; Zhou Y
Cardiovasc Diabetol; 2022 Jan; 21(1):11. PubMed ID: 35045846
[TBL] [Abstract][Full Text] [Related]
11. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
[TBL] [Abstract][Full Text] [Related]
12. The role of the plasma glycosylated hemoglobin A1c/Apolipoprotein A-l ratio in predicting cardiovascular outcomes in acute coronary syndrome.
Song F; Zhou Y; Zhang K; Liang YF; He X; Li L
Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):570-578. PubMed ID: 33358616
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of glycated hemoglobin among patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis.
Li G; Hou X; Li Y; Zhang P; Zhao Q; Li J; Shi J
Clin Chem Lab Med; 2017 Jul; 55(8):1090-1099. PubMed ID: 27816956
[TBL] [Abstract][Full Text] [Related]
14. Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 7.0.
Ouchi S; Shimada K; Miyazaki T; Takahashi S; Sugita Y; Shimizu M; Murata A; Kadoguchi T; Kato T; Aikawa T; Suda S; Sai E; Hiki M; Iwata H; Kasai T; Miyauchi K; Daida H
Cardiovasc Diabetol; 2017 Nov; 16(1):151. PubMed ID: 29157245
[TBL] [Abstract][Full Text] [Related]
15. Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61.
Winzap P; Davies A; Klingenberg R; Obeid S; Roffi M; Mach F; Räber L; Windecker S; Templin C; Nietlispach F; Nanchen D; Gencer B; Muller O; Matter CM; von Eckardstein A; Lüscher TF
Cardiovasc Diabetol; 2019 Oct; 18(1):142. PubMed ID: 31672144
[TBL] [Abstract][Full Text] [Related]
16. Elevated homocysteine level and prognosis in patients with acute coronary syndrome: a meta-analysis.
Zhu M; Mao M; Lou X
Biomarkers; 2019 Jun; 24(4):309-316. PubMed ID: 30821522
[No Abstract] [Full Text] [Related]
17. New-onset hyperglycemia and acute coronary syndrome: a systematic overview and meta-analysis.
Angeli F; Verdecchia P; Karthikeyan G; Mazzotta G; Del Pinto M; Repaci S; Gatteschi C; Gentile G; Cavallini C; Reboldi G
Curr Diabetes Rev; 2010 Mar; 6(2):102-10. PubMed ID: 20034367
[TBL] [Abstract][Full Text] [Related]
18. Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes.
Lettino M; Andell P; Zeymer U; Widimsky P; Danchin N; Bardaji A; Barrabes JA; Cequier A; Claeys MJ; De Luca L; Dörler J; Erlinge D; Erne P; Goldstein P; Koul SM; Lemesle G; Lüscher TF; Matter CM; Montalescot G; Radovanovic D; Sendón JL; Tousek P; Weidinger F; Weston CFM; Zaman A; Li J; Jukema JW;
Eur Heart J Cardiovasc Pharmacother; 2017 Oct; 3(4):198-213. PubMed ID: 28329196
[TBL] [Abstract][Full Text] [Related]
19. Hemoglobin A1c is a better predictor of prognosis following the non-ST elevation acute coronary syndrome than fasting and admission glucose.
Kmet M; Rajer B; Pernat A
Wien Klin Wochenschr; 2014 Mar; 126(5-6):156-62. PubMed ID: 24297265
[TBL] [Abstract][Full Text] [Related]
20. Short-term and long-term prognostic value of circulating soluble suppression of tumorigenicity-2 concentration in acute coronary syndrome: a meta-analysis.
Gu L; Li J
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092701
[No Abstract] [Full Text] [Related]
[Next] [New Search]
